Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 4Unknown 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Prostatic Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 2Cholangiocarcinoma 2Carcinoma, Intraductal, Noninfiltrating 2Sarcoma 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Lymphedema 1Lymphatic Metastasis 1Lung Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Endometrial Neoplasms 1Encopresis 1Carcinoma, Non-Small-Cell Lung 1Breast Carcinoma In Situ 1Breast Cancer Female 1

Interventions

Radiotherapy 11pembrolizumab 10Nivolumab 10Doxorubicin 10Magnetic Resonance Spectroscopy 9Specimen Handling 8Cyclophosphamide 8Biopsy 7X-Rays 6Ipilimumab 6Radiation 5Phantoms, Imaging 5Ifosfamide 5talimogene laherparepvec 4cabozantinib 4Nuclear Medicine Department, Hospital 4Irinotecan 4tazemetostat 3selpercatinib 3pazopanib 3liposomal doxorubicin 3fludarabine 3Temozolomide 3Etoposide 3ulixertinib 2tislelizumab 2tipifarnib 2palbociclib 2larotrectinib 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Sarcoma × Radiation Dose Hypofractionation × Clear all
NCT03972930 2026-05-12

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

University of Wisconsin, Madison

Phase 2 Active not recruiting
48 enrolled 10 charts
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡